<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Autoimmune complications in the context of primary <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> diseases represent a well-known phenomenon, and this is widely recognized also for <z:e sem="disease" ids="C0162538" disease_type="Disease or Syndrome" abbrv="IGAD1">Selective Immunoglobulin A deficiency</z:e> (IgAD), the most common primary antibody deficiency (PAD) </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0032453" disease_type="Disease or Syndrome" abbrv="">Relapsing polychondritis</z:e> (RP) is a rare immune-mediated, difficult to treat, disorder in which the cartilaginous tissues are the target for <z:mp ids='MP_0001845'>inflammation</z:mp> and damage </plain></SENT>
<SENT sid="2" pm="."><plain>Ocular inflammatory manifestations in RP are frequent and often sight-threatening </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> (APS) is an acquired prothrombotic state related to circulating autoantibodies against <z:chebi fb="1" ids="16247">phospholipids</z:chebi> and/or their cofactors </plain></SENT>
<SENT sid="4" pm="."><plain>Rare reports of APS associated to RP, PAD and APS or PAD and RP are available </plain></SENT>
</text></document>